Gen-Probe Launches In Europe CE-Marked APTIMA(R) HPV Assay For Detection Of Human Papillomavirus
Jun 1st 2008Drug InformationCervical Cancer
Gen-Probe Incorporated (Nasdaq: GPRO) announced that the Company has launched in Europe its APTIMA(R) HPV Assay, a highly specific molecular diagnostic test to detect high-risk strains of the human papillomavirus (HPV), which causes cervical cancer. The APTIMA HPV Assay has been CE marked and is currently available for sale in 13 European Union countries.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
